Profil Perusahaan

Organon Pharma Indonesia Tbk.

Code : SCPI
Name : Organon Pharma Indonesia Tbk.
Type : Emiten

Address
: Sinarmas MSIG Tower, Lantai 37, unit 102 & 106, Jalan Jenderal Sudirman Kaveling 21, Karet, Setiabudi, Jakarta Selatan - 12920
Email : arie.noviandari.arie.noviandari@organon.com
Phone : 085951102178
Fax : (021) 31107009
Website : https://www.organon.com/indonesia/

Business
: Pharmaceuticals
Sector Code : F. Healthcare
Sector Name : F2. Pharmaceuticals & Health Care Research
Industry : F21. Pharmaceuticals
Sub Industry : F211. Pharmaceuticals

Company Status
: PMDN

Foundation Status
: 1972-03-07

Brief of Company Background

Originally founded in 1972 as PT Essex Indonesia, the company is a joint venture between Bernard Murimboh of Indonesia and Schering Corporation of the United States. Prior to going public in 1990, the company changed its name to Schering Plough Indonesia. Products manufactured in its Surabaya plant include GARAMYCIN and NETROMICYN injectable antibiotics, Betamenthasone Dipropionate and Valerate creames for skin diseases, CLARITIN and CLARINASE for allergy disorders. The company currently uses PT Anugerah Pharmindo Lestari as a sole distributor. Recently, new products in Hepatitis and Cancer, INTRON-A and FUGEREL as well as in Dermatology, LOTRIDERM and ELOCON were introduced to the Indonesian market. In 1995 a highly effective antibiotic CEDAX was also launched. The company was ranked the best in the pharmaceutical sector in 1996 based on fundamental and technical ratings in the stock exchange



Shareholder List
NOShareholder NamePercentage
1Organon LLC98.7870%
2Public1.2130%

Management

Commissioners
President   :   Andreas Daugaard Jorgensen
Vice President   :  
Commissioners   :   Erwin Agung, Gideon Adi Siallagan
Directors
President   :   Daniel
Vice President   :  
Directors   :   Andri Soelastyo, Yeap Xin Yi, Yohanes Indrayana